Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voraxaze in patients with delayed methotrexate clearance
NCT00424645Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2007
- Primary completion
- Jan 2008
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucarpidase in Methotrexate toxicity, sponsored by University of Texas MD Anderson Cancer Center. Started Jan 2007; status: terminated.
02
Drugs
glucarpidase
03
Conditions
Methotrexate toxicity
Beyond the preview
Go deeper on NCT00424645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424645.